ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Lopéramide Sandoz®:Sandoz Pharmaceuticals AG
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
A07DA03 - LoperamideATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A07 - Antidiarrheals, Intestinal Antiinflammatory/Antiinfective Agents
 
A07D - Antipropulsives
 
A07DA - Antipropulsives

This group comprises agents which reduce gastrointestinal motility, e.g. diphenoxylate and loperamide. Loperamide and loperamide oxide are classified at the two separate 5th levels.
A07DA01 - diphenoxylate - includes combinations with atropine.
A07DA02 - opium - includes also combinations with belladonna and/or bismuth subgallate, albumin etc.
A07DA52 - morphine, combinations includes combinations with e.g. aluminum hydroxide, belladonna alkaloids and kaolin used as antipropulsives. Morphine combinations used in the treatment of pain are classified in N02AA51.
Combinations with antiflatulents are classified here.

The DDDs are based on treatment of acute diarrhea.

A07DA03 - Loperamide
Concentr.Adm.RouteNote
 O 
2024 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home